How sleep problems contribute to simulator sickness: Preliminary results from a realistic driving scenario.


Journal

Journal of sleep research
ISSN: 1365-2869
Titre abrégé: J Sleep Res
Pays: England
ID NLM: 9214441

Informations de publication

Date de publication:
04 2019
Historique:
received: 16 10 2017
revised: 18 01 2018
accepted: 18 01 2018
pubmed: 18 4 2018
medline: 13 3 2020
entrez: 18 4 2018
Statut: ppublish

Résumé

Virtual reality and simulation tools enable us to assess daytime functioning in environments that simulate real life as close as possible. Simulator sickness, however, poses a problem in the application of these tools, and has been related to pre-existing health problems. How sleep problems contribute to simulator sickness has not yet been investigated. In the current study, 20 female chronic insomnia patients and 32 female age-matched controls drove in a driving simulator covering realistic city, country and highway scenes. Fifty percent of the insomnia patients as opposed to 12.5% of controls reported excessive simulator sickness leading to experiment withdrawal. In the remaining participants, patients with insomnia showed overall increased levels of oculomotor symptoms even before driving, while nausea symptoms further increased after driving. These results, as well as the realistic simulation paradigm developed, give more insight on how vestibular and oculomotor functions as well as interoceptive functions are affected in insomnia. Importantly, our results have direct implications for both the actual driving experience and the wider context of deploying simulation techniques to mimic real life functioning, in particular in those professions often exposed to sleep problems.

Identifiants

pubmed: 29664207
doi: 10.1111/jsr.12677
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12677

Subventions

Organisme : LabEx Brain
ID : ANR-10-LABX-43
Pays : International
Organisme : EquipEx Phenovirt
ID : ANR-10-EQPX-01
Pays : International

Informations de copyright

© 2018 European Sleep Research Society.

Auteurs

Ellemarije Altena (E)

Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.
CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.

Yannick Daviaux (Y)

Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.
CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.

Ernesto Sanz-Arigita (E)

UMR 5287-CNRS, INCIA- Univ. Bordeaux, F-33000, Bordeaux, France.

Emilien Bonhomme (E)

Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.
CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.

Étienne de Sevin (É)

Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.
CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.

Jean-Arthur Micoulaud-Franchi (JA)

Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.
CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.
Clinique du sommeil, CHU Pellegrin, place Amélie-Raba-Léon, 33076, Bordeaux, France.

Stéphanie Bioulac (S)

Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.
CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.
Clinique du sommeil, CHU Pellegrin, place Amélie-Raba-Léon, 33076, Bordeaux, France.

Pierre Philip (P)

Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.
CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.
Clinique du sommeil, CHU Pellegrin, place Amélie-Raba-Léon, 33076, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH